当前蛋白身份:P04233 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1A6A THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3 提交 1998-02-22 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 103–117(15 aa) 片段:CLIP FRAGMENT 87 - 101 OF INVARIANT CHAIN
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 4.5;12% PEG 4K, 100 MM MGCL2, 100 MM ACETATE BUFFER, PH 4.5
分辨率 2.75 Å R-free 0.325
1A6A THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3 提交 1998-02-22 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 C 103–117(15 aa) 片段:CLIP FRAGMENT 87 - 101 OF INVARIANT CHAIN
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 X-RAY DIFFRACTION
X-ray结晶条件 pH 4.5;12% PEG 4K, 100 MM MGCL2, 100 MM ACETATE BUFFER, PH 4.5
分辨率 2.75 Å R-free 0.325
1ICF CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L 提交 1999-01-07 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 I 210–274(65 aa) 片段:THYROGLOBULIN TYPE-1 DOMAIN
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.1;SITTING DROP VAPOR DIFFUSION METHOD RESERVOIR CONTAINED 1ML OF 0.2 M NA- ACETATE TRIHYDRATE, 30% W/V PEG 8K AND 0.1M MES, PH 6.1. DROP WAS COMPOSED OF 2 MICRO L OF RESERVOIR SOLUTION AND 2 MICRO L OF THE COMPLEX (10 MG/ML) IN 20MM NA-ACETATE AND 1MM EDTA, PH 5.0.
分辨率 2.00 Å R-free 0.213
1ICF CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L 提交 1999-01-07 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 J 210–274(65 aa) 片段:THYROGLOBULIN TYPE-1 DOMAIN
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.1;SITTING DROP VAPOR DIFFUSION METHOD RESERVOIR CONTAINED 1ML OF 0.2 M NA- ACETATE TRIHYDRATE, 30% W/V PEG 8K AND 0.1M MES, PH 6.1. DROP WAS COMPOSED OF 2 MICRO L OF RESERVOIR SOLUTION AND 2 MICRO L OF THE COMPLEX (10 MG/ML) IN 20MM NA-ACETATE AND 1MM EDTA, PH 5.0.
分辨率 2.00 Å R-free 0.213
1ICF CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L 提交 1999-01-07 Assembly 3 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 I 210–274(65 aa) 片段:THYROGLOBULIN TYPE-1 DOMAIN
链 J 210–274(65 aa) 片段:THYROGLOBULIN TYPE-1 DOMAIN
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.1;SITTING DROP VAPOR DIFFUSION METHOD RESERVOIR CONTAINED 1ML OF 0.2 M NA- ACETATE TRIHYDRATE, 30% W/V PEG 8K AND 0.1M MES, PH 6.1. DROP WAS COMPOSED OF 2 MICRO L OF RESERVOIR SOLUTION AND 2 MICRO L OF THE COMPLEX (10 MG/ML) IN 20MM NA-ACETATE AND 1MM EDTA, PH 5.0.
分辨率 2.00 Å R-free 0.213
1IIE HLA-DR ANTIGENS ASSOCIATED INVARIANT CHAIN 提交 1999-02-02 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 118–192(75 aa) 片段:ECTOPLASMIC TRIMERIZATION DOMAIN (RESIDUES 118-192)
链 B 118–192(75 aa) 片段:ECTOPLASMIC TRIMERIZATION DOMAIN (RESIDUES 118-192)
链 C 118–192(75 aa) 片段:ECTOPLASMIC TRIMERIZATION DOMAIN (RESIDUES 118-192)
未记录 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 6.7;298 K;压力 1
分辨率未提供
1L3H NMR structure of P41icf, a potent inhibitor of human cathepsin L 提交 2002-02-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 210–274(65 aa) 片段:THYROGLOBULIN-LIKE DOMAIN
未记录 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 5.7;288 K;压力 ambient
NMR样品组成 1mM P41icf; 20mM phosphate buffer, 0.01mM NaN3 | 85% H20, 15% D2O
分辨率未提供
3PDO Crystal Structure of HLA-DR1 with CLIP102-120 提交 2010-10-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 102–120(19 aa)
未记录 GOL GLYCEROL × 2 FMT FORMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;298 K;PEG 3350, NaCitrate, VAPOR DIFFUSION, SITTING DROP, temperature 298K
分辨率 1.95 Å R-free 0.240
3PGC Crystal Structure of HLA-DR1 with CLIP106-120, flipped peptide orientation 提交 2010-11-01 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 106–120(15 aa) 片段:UNP residues 106-120
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;PEG 1500, MIB buffer, pH 6.0, vapor diffusion, sitting drop, temperature 298K
分辨率 2.66 Å R-free 0.250
3PGC Crystal Structure of HLA-DR1 with CLIP106-120, flipped peptide orientation 提交 2010-11-01 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 F 106–120(15 aa) 片段:UNP residues 106-120
未记录 PEG DI(HYDROXYETHYL)ETHER × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;PEG 1500, MIB buffer, pH 6.0, vapor diffusion, sitting drop, temperature 298K
分辨率 2.66 Å R-free 0.250
3PGD Crystal Structure of HLA-DR1 with CLIP106-120, canonical peptide orientation 提交 2010-11-01 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 106–120(15 aa) 片段:UNP residues 106-120
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;PEG 3350, NaCitrate, BisTris propane, pH 6.5, vapor diffusion, sitting drop, temperature 277K
分辨率 2.72 Å R-free 0.242
3PGD Crystal Structure of HLA-DR1 with CLIP106-120, canonical peptide orientation 提交 2010-11-01 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 F 106–120(15 aa) 片段:UNP residues 106-120
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;PEG 3350, NaCitrate, BisTris propane, pH 6.5, vapor diffusion, sitting drop, temperature 277K
分辨率 2.72 Å R-free 0.242
3QXA HLA-DR1 bound with CLIP peptide 提交 2011-03-01 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 103–117(15 aa) 片段:CLIP region
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.6;277 K;PEG 4000, 10% Glycerol, 100mM Sodium Acetate pH 5.6, 5mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.71 Å R-free 0.235
3QXA HLA-DR1 bound with CLIP peptide 提交 2011-03-01 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 F 103–117(15 aa) 片段:CLIP region
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.6;277 K;PEG 4000, 10% Glycerol, 100mM Sodium Acetate pH 5.6, 5mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.71 Å R-free 0.235
3QXD F54C HLA-DR1 bound with CLIP peptide 提交 2011-03-01 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 103–117(15 aa) 片段:CLIP region
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.6;277 K;PEG 4000, 10% Glycerol, 100mM Sodium Acetate pH 5.6, 5mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.30 Å R-free 0.221
3QXD F54C HLA-DR1 bound with CLIP peptide 提交 2011-03-01 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 F 103–117(15 aa) 片段:CLIP region
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.6;277 K;PEG 4000, 10% Glycerol, 100mM Sodium Acetate pH 5.6, 5mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.30 Å R-free 0.221
4AEN HLA-DR1 with covalently linked CLIP106-120 in reversed orientation 提交 2012-01-11 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 106–120(15 aa) 片段:RESIDUES 106-120
未记录 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 2 M (NH4)2SO4, 0.1 M TRIS, PH 8.0
分辨率 2.20 Å R-free 0.221
4AH2 HLA-DR1 with covalently linked CLIP106-120 in canonical orientation 提交 2012-02-03 Assembly 1 信息不足 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 106–120(15 aa) 片段:EXTRACELLULAR DOMAIN, RESIDUES 106-120,30-227
未记录 GOL GLYCEROL × 4 X-RAY DIFFRACTION
X-ray结晶条件 pH 7;0.2 M LICL, 20% (W/V) PEG6000, 0.1 M HEPES, PH 7.0
分辨率 2.36 Å R-free 0.240
4X5W HLA-DR1 with CLIP102-120(M107W) 提交 2014-12-06 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 102–120(19 aa) 片段:extracellular, UNP residues 102-120
突变:M107W 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;298 K;0.2 M K/Na-tartrate, 20% (w/v) PEG3350, 0.1M BisTrisPropane, pH 8.5
分辨率 1.34 Å R-free 0.170
8VRW Cryo-EM structure of human invariant chain in complex with HLA-DR15 提交 2024-01-22 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 9 PDB 声明:nonameric(9) 与蛋白数一致
链 C 2–296(295 aa)
链 F 2–296(295 aa)
链 I 2–296(295 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.03 Å
8VSJ Engineered peptide-specific binder in complex with HLA-DR1/CLIP 提交 2024-01-24 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 P 103–117(15 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.3
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.28 Å
8VSP Cryo-EM structure of human invariant chain in complex with HLA-DQ 提交 2024-01-24 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 9 PDB 声明:nonameric(9) 与蛋白数一致
链 C 2–296(295 aa)
链 F 2–296(295 aa)
链 I 2–296(295 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.12 Å
9CYL Structure of LAG3 loop1 deletion bound to the MHC class II molecule I-A(b) 提交 2024-08-02 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 P 103–117(15 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;293.15 K;1% w/v Tryptone, 0.001 M Sodium azide, 0.05 M HEPES sodium pH 7.0, 12% w/v Polyethylene glycol 3,350
分辨率 4.66 Å R-free 0.326
9CYM Structure of LAG3 bound to the MHC class II molecule I-A(b) 提交 2024-08-02 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 P 103–117(15 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;0.15 M Ammonium sulfate, 0.1 M Tris 8.0 and 15 % w/v PEG 4000
分辨率 3.84 Å R-free 0.307
9EJH Peptide-independent T cell receptor recognition of HLA-DQ2 提交 2024-11-27 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 C 110–122(13 aa) 片段:UNP residues 110-122
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ACT ACETATE ION × 4 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;8% Tacsimate, pH 8.0, 20-24% w/v PEG3350
分辨率 2.45 Å R-free 0.232